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We recently identified two loci, mel1 and mel2, that affect macrophage infection by Mycobacterium marinum.
The ability of these loci to confer enhanced infection in trans is presumably due to gene dosage effects since
their presence on plasmids increases expression from five- to eightfold. Reasoning that this phenomenon would
allow identification of other mycobacterial genes involved in macrophage infection, we conducted a screen of
an M. marinum DNA library that provides 2.6-fold coverage of the entire genome for clones that affect
macrophage infection. Our preliminary screen identified 76 plasmids that carry loci affecting macrophage
infection. We eliminated plasmids that do not confer the expected phenotype when retransformed (70%), that
have identical physical maps (5%), or that carry either of the mel1 or mel2 loci (14%) from further consider-
ation. Four loci that confer enhanced infection (mel) and four that confer repressed infection (mrl) of
macrophages were identified, and two of each group were chosen for detailed analysis. Saturating transposon
mutagenesis was used to identify the loci responsible, and M. marinum mutants were constructed in the genes
involved. We expect these genes to provide insight into how mycobacteria parasitize macrophages, an impor-
tant component of innate immunity.
Mycobacterium marinum is a natural pathogen of humans
(41, 49, 57), fish, and amphibians (18), causing more than 150
human infections each year in the United States alone (29).
Although M. marinum causes primarily skin lesions on the
extremities in humans (19), it causes a systemic tuberculous
disease in fish and amphibians (30, 73, 101). M. marinum in-
fections result in granuloma formation, whether in humans,
mice, fish, or amphibians (18–20, 101). Granuloma formation
occurs because macrophages become infected and allow
growth of M. marinum during disease (19, 74) and in labora-
tory model systems (7, 33, 69, 81). These characteristics of
infections, along with the relative ease of manipulation (3, 37,
82, 88), rapid growth rate compared to other pathogenic my-
cobacteria (18), and the presence of numerous useful virulence
models (11, 20, 27, 33, 84, 89, 92), have aroused great interest
in the molecular mechanisms of M. marinum pathogenesis.
Significant progress has been made toward understanding M.
marinum evolution (106), trafficking (7, 86, 98), secretion (1,
36), gene regulation (6, 82), photochromogenicity (35, 83), cell
wall synthesis (3, 24, 37), granuloma formation (23, 27, 97),
resistance to oxidative species (78, 79, 95, 96), and mechanisms
of macrophage infection (32, 38, 66).
As a means to better understand the molecular mechanisms
of macrophage infection by M. marinum, we recently screened
a genomic library for loci that have the ability to confer en-
hanced macrophage infection to M. smegmatis (32), a non-
pathogenic mycobacterial species that does not infect macro-
phages efficiently. We identified two M. marinum loci, mel1
and mel2, that confer enhanced macrophage infection to both
M. smegmatis and M. marinum. The phenotypic effect of cos-
mids containing mel loci in M. marinum suggests that gene
dosage effects, due to the resulting gene copy number, increase
the expression of these genes above basal levels and thereby
increase the efficiency of macrophage infection. This conclu-
sion is consistent with our previous observations, and that of
other groups, that many pathogenic bacteria, including other
mycobacteria, are more virulent when grown in eukaryotic cells
than when grown in laboratory medium (12–15, 65). If these
hypotheses are correct, gene dosage effects could be used to
identify additional genes that play a role in macrophage infec-
tion through screening a M. marinum genomic library in wild-
type M. marinum for enhanced macrophage infection under
standard laboratory growth conditions.
In the present study, we demonstrate the feasibility of this
approach by evaluating the efficiency of macrophage infection
under different stages of M. marinum growth when cultured in
laboratory medium. We also confirm the ability of the mel1 and
mel2 loci to confer enhanced infection of macrophages to M.
marinum when carried on plasmids and evaluate the ability of
gene dosage effects to increase levels of melF expression, the
first gene in the mel2 locus. These observations led us to
conduct a whole-genome screen in M. marinum for macro-
phage infection loci using gene dosage effects. We identified a
total of eight loci: four that enhance and four that repress
macrophage infection. Detailed characterization of four of
these loci resulted in the identification of at least seven newly
described genes that play a role in macrophage infection by M.
marinum. These observations suggest, for the first time, that M.
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marinum has the ability to modulate infection of macrophages
in both a positive and negative manner, which may play a
previously under appreciated role in pathogenesis.
MATERIALS AND METHODS
Strains and growth conditions. M. marinum strain M, a clinical isolate ob-
tained from the skin of a patient (81), was used in these studies. M. marinum
strains were grown at 33°C in 7H9 broth (Difco, Detroit, MI) supplemented with
0.5% glycerol, 10% albumin-dextrose complex (ADC), and 0.25% Tween 80
(M-ADC-TW) for 5 days. Cultures were grown to an optical density at 600 nm
(OD600) of 0.5 (except where specifically indicated otherwise), mixed vigorously
using a vortex for 1 min, passed through a 27-gauge syringe needle twice, and
allowed to settle for 5 min prior to taking aliquots from the top half of the culture
for use in assays to ensure single-cell suspensions were used in all assays. The
number of viable bacteria was determined for each assay using the Live/Dead
assay (Molecular Probes, Eugene, OR) and by plating dilutions for CFU on 7H9
(M-ADC) agar (Difco). All inocula used were 99% viable. Escherichia coli
strain XL1-Blue (Stratagene) was grown in Luria-Bertani (LB) medium (Difco)
at 37°C. Where appropriate, kanamycin or chloramphenicol were added at a
concentration of 25 g/ml (E. coli) or 10 g/ml (M. marinum). X-Gal (5-bromo-
4-chloro-3-indolyl--D-galactopyranoside) was added at concentrations of 40
g/ml in E. coli and 80 g/ml in M. marinum, when needed.
Monocytic cell lines and culture conditions. The murine macrophage cell lines
RAW 264.7 (ATCC CRL-2278) and J774A.1 (ATCC TIB67) were maintained in
5% CO2 at 37°C in high-glucose Dulbecco modified Eagle medium (Gibco,
Bethesda, MD) supplemented with 10% heat-inactivated fetal bovine serum
(Gibco) and 2 mM L-glutamine. The human monocytic cell line THP-1 (ATCC
TIB202) was maintained at 37°C and 5% CO2 in RPMI medium supplemented
with 10% heat-inactivated fetal bovine serum and 2 mM L-glutamine. The ad-
herent carp monocytic/macrophage cell line CLC (European Collection of Cell
Cultures no. 95070628) was maintained at 28°C and 5% CO2 using high-glucose
minimal essential medium (Gibco) supplemented with 1% nonessential amino
acids, 10% heat-inactivated fetal bovine serum (Gibco), and 2 mM L-glutamine.
Cell viability was determined for all cell lines by exclusion of trypan blue as
described previously (95). The cell viability for all cells in all assays was 90%.
M. marinum growth phase and entry assays. M. marinum was inoculated at an
OD600 of 0.01 (3  106 CFU/ml) in 100 ml of M-ADC-TW and grown at 33°C.
Aliquots were taken at various time points, the OD600 was measured, and
dilutions were plated on M-ADC plates to determine CFU. At each time point
entry assays were performed using the bacteria in the aliquots at a multiplicity of
infection (bacteria/host cells) of 10. Entry assays were carried out as described
previously for J774A.1, RAW 264.7, and THP-1 cells (32) and for CLC cells (33).
Basically, approximately 106 cells were infected for 30 min, washed twice with
phosphate-buffered saline (PBS), and incubated in fresh medium for 2 h with 200
g of amikacin/ml at 37°C to kill extracellular bacteria. The cells were then
washed with PBS, lysed with 0.1% Triton X-100, and dilutions were plated on
M-ADC to determine the intracellular CFU. The percent entry was then calcu-
lated as follows: (CFUintracellular/CFUinoculum)  100.
Determination of RNA transcript levels. Reverse transcription-PCR (RT-
PCR) was used to quantify levels of 16S rRNA, melF, melM, melN, melO, and
melP transcription in different mycobacterial strains within the linear amplifica-
tion range, as described previously (96). Basically, 300 to 500 ng of DNase-
treated, total bacterial RNA was mixed with gene-specific reverse primers (Table
1), deoxynucleoside triphosphate mix and 40 U of RNaseOUT, incubated at 65°C
for 5 min, and placed on ice prior to use. The annealed primers were extended
with 15 U of Thermoscript RT at 55°C for 60 min, followed by heat inactivation
of the enzyme at 85°C for 5 min. The residual, nontranscribed RNA were
removed with 2 U of E. coli RNase H at 37°C for 20 min. Then, 2 l of the cDNA
was used in PCR amplification with 1 mM appropriate forward and reverse
primers (Table 1) and 5 U of Thermopol enzyme (NEB) in a total volume of 50
l. The amplified products were analyzed by 0.8% agarose gel electrophoresis,
and the products for the appropriate dilutions of each target within the linear
amplification range were measured by densitometry semiquantitatively by using
a ChemiDoc XRS (Bio-Rad) and QuantityOne software.
In the case of quantitative RT-PCR, cDNA was synthesized by using Super-
script II and random decamers (Ambion). The primers corresponding to 16S
rRNA, sigA, melF, melM, melN, melO, melP, and mrlI (Table 1) were used to
amplify 10 ng of cDNA with Sybr GreenER qPCR SuperMix Universal (Invitro-
gen) in an Applied Biosystems 7500 RT-PCR system in triplicate. Products were
verified by agarose gel electrophoresis after amplification. Relative quantities of
RNA transcripts were calculated by using the comparative CT method with 16S
rRNA as an internal standard. The fold increase in expression was calculated by
the 2CT method, as described previously (9).
Construction of an arrayed M. marinum total DNA cosmid library in M.
marinum. A contiguous fragment library was constructed in the cosmid pJDC16
from M. marinum total DNA as described previously (32). The average fragment
size for DNA inserts in this library were between 40 and 50 kbp in length.
Approximately 20,000 cosmid clones from this library in E. coli were pooled and
plated for individual colonies on LB agar plus kanamycin. A total of 384 indi-
vidual colonies were picked and grown in 100 l of LB plus kanamycin in 96-well
microtiter dishes. A replica was made of this arrayed library, and both samples
were stocked in 50% glycerol and stored at80°C until use. The randomness and
integrity of the library was confirmed by restriction analysis of 20 random cos-
mids from the library. Of the 20 clones, 100% carried the appropriate size of
insert and displayed unique PstI physical maps. Plasmid was prepared from each
clone in the entire E. coli library and used to transform M. marinum by electro-
poration as described previously (16). One clone from each transformation was
grown in M-ADC-TW plus kanamycin and stored in 50% glycerol at 80°C in
96-well microtiter dishes until use.
M. marinum whole-genome screen for loci affecting macrophage infection. The
entire arrayed M. marinum genomic library carried by M. marinum was screened
for the effects of gene dosage on macrophage infection in RAW 264.7 cells.
Groups of between 5 and 12 clones from the library were grown separately and
evaluated in all assays, along with wild-type M. marinum and M. marinum that
carries the vector backbone pJDC16. All cultures for assays were grown in 1 ml
TABLE 1. Oligonucleotides
Namea Target geneb Sequence (5	–3	)
MelFF melF CAGAAGACGCGATCACGGCG
MelFR GGGTCGGCGAACACTTCACC
MelMF melM CCTGGACCTGCCGCGCCTTG
MelMR GTTCAGCGCCGCCAGCGTGG
MelNF melN CCCAGCGGCACATCACGGTG
MelNR CGCTGTGGTGGGCGTAGCCG
MelOF melO GACCCCTGCGCACCTCGCCG
MelOR CCGTCTGACCATCCGCACCG
MelPF melP CCCAACACTGTCCACCCTGG
MelPR CGTTGGCGGTGCAGGTCATC
MrlIF mrlI CCCGTTGGGACTGGCTAC
MrlIR GCCGAGGAGGTGCTATGA
SigAF sigA CCTCGACCTTGACGCCGCCG
SigAR GGCGCAGGTTGGCTTCCAGC
rRNAF 16S rRNA AGAGTTTGATCCTGGCTCAG
rRNAR CACGCTCACAGTTAAGCTGT
MelDF melD CTAGCGCAGCCTGGTAGTC
MelDR GCAAGAACCTGCATCTGGCC
MelF2F melF TCGGAATATTCCTCATGCCG
MelF2R GTTGGTCTTCGGTCCAGATC
MelLF melL TATAGCTAGCGAACCAAGCA
GCAATGACAG
MelLR TATATTAATTAAACAACATCA
GGCCCAGAAAG
MrlACF mrlA-C TATATTAATTAACGGCTGACT
TCCCGGATTCC
MrlACR TATATTAATTAACGAGGCCAT
GGTCGACCAGG
MrlFOF mrlF-O TATATTAATTAAAGCCACCG
GACATACGAC
MrlFOR TATAAGTACTGTGCCGTTCCC
ACAGTCC
MrlJOF mrlJ-O TATATTAATTAAACCGTCGAG
GTGATCGTG
MrlJOR TATAAGTACTGTGCCGTTCCC
ACAGTCC
a Suffixes: F, forward primer; R, reverse primer.
b That is, the target gene mRNA transcript for RT-PCR analyses or PCR or
target genes for the construction of the complementation constructs pJDC117
(melL), pJDC119 (mrlA-C), pJDC120 (mrlF-O), and pJDC121 (mrlJ-O). Oligo-
nucleotides are listed as primer pairs. Reverse primers were used for cDNA
synthesis, and both forward and reverse primers were used for RT-PCR and PCR
cloning.
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FIG. 1. Growth of M. marinum in M-ADC-TW broth as determined by OD600 (A) and CFU (B). The percentages of the M. marinum inoculum
that enters human monocytic/macrophage THP-1 (C), murine macrophage J774A.1 (D), and RAW 264.7 (F) cell lines and the fish monocytic/
macrophage CLC (E) cell line when grown to different optical densities are also shown. Each data point indicates the mean, and error bars indicate
the standard deviation of triplicate samples from a representative experiment of two independent experiments. **, P
 0.01 compared to the means
of data at OD600  0.3 to 0.5.
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of M-ADC-TW plus kanamycin and without kanamycin for the wild type without
vector. Monolayers of 106 RAW 264.7 cells were then infected with approxi-
mately 107 bacteria from each culture for 30 min at 37°C in 24-well tissue culture
dishes, washed three times with warm PBS, and lysed with 0.1% Triton X-100,
and dilutions were plated on M-ADC to determine cell-associated CFU. The per-
cent cell association was then calculated as follows: (CFUintracellular/CFUinoculum) 
100. In the initial screen, all assays were carried out in triplicate, and two
independent assays were carried out with each of the 384 clones in the library. All
data were normalized to the median cell association for all assays, arbitrarily set
to 1. Positive clones were chosen based on their significantly (P
 0.05) different,
either increased or decreased, cell association from the median. Cosmids were
then purified from all 76 positive clones, transferred to E. coli, physically mapped
with PstI and NotI, and screened for the presence of mel1 or mel2 genes (32) by
PCR using the oligonucleotide pairs MelDF-MelDR or MelF2F-MelF2R, re-
spectively. The cosmids were retransformed into M. marinum by electroporation
and reassayed for the effects on RAW 264.7 cell association in three independent
assays in triplicate. Cosmid clones that consistently conferred a difference in
macrophage infection in cell association assays were chosen for determination of
the genes involved.
Identification of mycobacterial enhanced and repressed macrophage infection
loci. Four cosmids were chosen for detailed characterization as described previ-
ously (32): two that confer enhanced macrophage infection (mel) and two that
confer repressed macrophage infection (mrl) to M. marinum. All four cosmids
were mutagenized by saturating transposon mutagenesis with the chloramphen-
icol-resistant mini-Mu transposon as recommended by the manufacturer of the
system (Finnzymes). Each mutagenized cosmid was transformed into M. mari-
num, and the resulting transformants were evaluated in three independent RAW
264.7 cell association assays in triplicate. Cosmids that no longer confer the
phenotype of the original cosmid, due to the presence of the transposon in the
locus involved, were purified and physically mapped with PstI and NotI, and
the sequence was obtained from the junction next to the transposon to determine
the gene interrupted using the SeqA and SeqB primers provided by the manu-
facturer.
In silico analysis of loci. Detailed analysis of the amino acid sequence of
putative open reading frames (ORFs) within mel and mrl loci was carried out by
using protein-protein National Center for Biotechnology Information BLAST
(5) and Conserved Domain Search (64) as described previously (32).
Construction ofM. marinummutants by allelic exchange. In order to construct
mutations in the M. marinum mel and mrl loci identified, we cloned each locus
into the unique BamHI, EcoRI, or HindIII site of pYUB174 for allelic exchange
as described previously (32). Each locus was in vitro mutagenized randomly using
a kanamycin-resistant mini-Mu transposon as recommended by the manufacturer
of the system (Finnzymes). Plasmids that carried mutations in genes of interest
were then transformed into M. marinum by electroporation, and recombinants
were selected for by the presence of kanamycin-resistant blue colonies on X-Gal
M-ADC plates. Individual colonies were then grown in the presence of kanamy-
cin, plated for single colonies on the same plates, and screened visually for white
colonies, which should be mutants resulting from allelic exchange. The presence
of the appropriate mutation was confirmed in each case by PCR and Southern
analyses.
Construction of complementing strains for each M. marinum mutant. Com-
plementing constructs were made for each region by high-fidelity PCR and cloning
into pJDC89 as described previously (66). Basically, the fragments were amplified by
PCR directly from M. marinum chromosomal DNA using oligonucleotides de-
scribed in Table 1 and cloned directionally into pJDC89 by using NheI and PacI
(pJDC117) or PacI and ScaI (pJDC119, pJDC120, and pJDC121). All constructs
were confirmed by physical mapping with restriction enzymes, and the absence of
mutations incorporated by PCR was demonstrated by sequencing.
Microscopic method to confirm efficiency of macrophage infection. Macro-
phage infection assays were conducted and evaluated by microscopy as described
previously (33). Coverslips were seeded with macrophages in 24-well tissue
culture plates. Bacteria were added to achieve a multiplicity of infection of 10.
The infection was allowed to proceed for 30 min, after which the cells were
washed twice with PBS. The cells were fixed with methanol, washed once with
PBS, and stained by the Ziehl-Neelsen technique (47), using carbol-fuchsin and
malachite green (Sigma). Cells were examined by using a Nikon TE300 light
microscope with differential interference contrast optics. At least two indepen-
dent coverslips were examined for each sample. The percentage of infected cells
was determined for three counts of 25 fields, each with greater than 20 cells per
field. The number of bacterial vacuoles per cell was determined for three counts
of 50 cells each, and the number of bacteria per vacuole was determined for three
counts of 50 cells each. These values were used to calculate an infectivity index
for each mutant as the (percent infected cells  the number of vacuoles per
cell the number of bacteria per vacuole for strain)/(percent infected cells the
number of vacuoles per cell  the number of bacteria per vacuole for M.
marinum). All microscopy samples were coded to allow blinded examination.
Statistical analyses. All experiments were carried out in triplicate and re-
peated at least three times, except where specifically noted. The significance of
the results was determined by using the Student t test or analysis of variance,
where appropriate. P values of 
0.05 were considered significant.
RESULTS
Macrophage infection by M. marinum is regulated. Genes
involved in the virulence of bacterial pathogens are usually
tightly regulated under different environmental conditions to
allow economic use of available nutritional resources (28, 67,
68, 85). We examined the ability of M. marinum to infect
macrophages during growth in laboratory medium to better
understand how the genes involved might be regulated and
their mechanism of action. M. marinum displays approximately
10- to 20-fold-higher levels of macrophage infection at an
OD600 of between 0.8 and 1.2 compared to early or late stages
of growth (Fig. 1). This difference is consistent in human,
murine, and fish monocytic cells and macrophages, although
there are some differences in the magnitude of the effect seen.
Since all assays, irrespective of the growth state of the bacteria,
were conducted with the same number of bacteria in the same
fashion, it is unlikely that this difference is due to experimental
conditions other than regulation of the M. marinum factors
involved.
Gene dosage effects allow subtle upregulation of genes inM.
marinum. Our previous studies allowed identification of two
FIG. 2. Percentage of the bacterial inoculum that enters murine
macrophage RAW 264.7 cells for wild-type M. marinum and M. ma-
rinum that carry cosmids that have the mycobacterial enhanced infec-
tion loci mel1 (M. marinum::cos20) and mel2 (M. marinum::cos31). All
culture densities were approximately 0.5 at 600 nm. Each point repre-
sents the mean of triplicate samples. The line for each strain represents
the mean of the three independent experiments. **, P 
 0.001 com-
pared to wild-type M. marinum.
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loci, mel1 and mel2, from M. marinum that have the ability to
confer enhanced infection of macrophages to M. smegmatis, a
nonpathogenic mycobacterial species (32). Since mutations in
these loci affect the ability of M. marinum to infect macro-
phages, their regulation may be at least partially responsible
for the differences in efficiency of macrophage infection ob-
served at different stages of growth in laboratory medium.
Based on these observations, we hypothesized that M. mari-
num containing plasmids that carry the mel loci would upregu-
late these genes and display enhanced macrophage infection
compared to wild-type bacteria. We found that cosmids con-
taining the mel1 or mel2 loci confer 10-fold-enhanced infec-
tion of macrophages to M. marinum (Fig. 2). When we exam-
ined the level of expression of mel2 in wild-type M. marinum
and the strain carrying the cosmid that contains mel2, we found
that expression of the melF gene within this locus increases at
least fivefold (Fig. 3). These observations suggest that gene
dosage effects can be used to increase the expression of genes
involved in macrophage infection and raises the possibility that
this technique could be used to identify additional macrophage
infection genes.
Whole-genome screen for M. marinum genes involved in
macrophage infection. In order to gain additional insight into
the mechanisms of macrophage infection by M. marinum, we
developed a strategy using gene dosage effects to screen the M.
marinum genome. We first constructed a total DNA genomic
cosmid library that can replicate in both E. coli and M. mari-
num (32). We arrayed 384 individual E. coli clones from this
library in four 96-well plates, transformed each of these cos-
mids into M. marinum, and arrayed the resulting transformants
in 96-well plates in the same manner. Since the average frag-
ment size for the cosmid library is 45 kbp and the M. mari-
num genome is 6.6 Mbp, 384 clones provide 2.6-fold cov-
erage of the entire M. marinum genome or a 93% likelihood
FIG. 3. RT-PCR (A and B) and quantitative RT-PCR (C) studies to evaluate the effects of gene dosage on expression of melF in M. marinum.
Equivalent amounts of RNA from M. marinum wild-type and M. marinum carrying cos31 (M. marinum::cos31) were reverse transcribed and
subjected to PCR using specific oligonucleotides within melF and 16S rRNA. (A) The dilutions of cDNAs are, from left to right: 1:4, 1:2, and 1:1.
Equal amounts of each PCR product were loaded on 0.8% agarose gels and compared to the 16S rRNA control RT-PCR for each strain (16S
rRNA) carried out on the same samples in the same manner by ethidium bromide staining (A) and densitometry (B). (C) Quantitative RT-PCR
analyses of increased expression levels of RNA transcript in M. marinum carrying cos31 compared to wild-type M. marinum confirmed conventional
RT-PCR studies. In the case of quantitative RT-PCR, the sigA gene was used as a control that should not display changes in expression in the
presence of the cosmids. All transcript levels were calculated by the comparative CT method using 16S rRNA as a comparator. The data shown
are representative of two independent experiments. **, P 
 0.05 compared to sigA.
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that the entire genome is represented in the library. Each of
the resulting M. marinum clones carrying a cosmid with a large
fragment of the M. marinum genome was then screened in two
independent assays in triplicate for the ability to infect macro-
phages (Fig. 4). We chose to avoid use of antibiotics in this
screen to eliminate the possibility that some of the differences
observed would be due to differences in antibiotic susceptibil-
ity, rather than interactions with macrophages. To normalize
our data, the median level of macrophage infection for the
entire library was set to 1, and results from each assay were
evaluated for significant differences from the median (P 

0.05). Interestingly, an approximately equivalent number of
clones display decreased (repressed) and increased (enhanced)
macrophage infection in these assays. Since it is possible that
repression of host cell infection is equally as important as
enhancement of host cell infection during pathogenesis, we
selected both types of clones for further analyses. A total of 76
clones had significantly enhanced or repressed macrophage
infection in our initial screen.
Confirmation of the ability of cosmids to confer effects on
macrophage infection. Individual cosmids that we isolated
from the 76 M. marinum clones displaying enhanced or re-
pressed macrophage infection were screened for similar phys-
ical maps, the presence of previously identified loci, and the
ability to confer the expected phenotype when transformed
back into M. marinum. Restriction patterns with PstI and NotI
were examined for all 76 cosmids (data not shown). Four
plasmids with identical restriction patterns were identified and
eliminated from further analyses. In addition, we examined
each cosmid for the presence of either mel1 or mel2 by PCR
(data not shown), since these loci had been previously shown to
confer enhanced macrophage infection. We identified 11
clones out of 76 that carry either mel1 or mel2, and these clones
were not analyzed further. Transformation of cosmids back
into M. marinum was used to confirm their phenotype and
ensure that it is due to genes present on the cosmid, rather
than a mutation in the M. marinum chromosome. All 76 clones
resulting from transformation of these cosmids back into M.
marinum were assayed in triplicate in three independent assays
in the same manner as our initial screen (Fig. 5). We identified
eight cosmid clones that confer significantly enhanced or re-
pressed macrophage infection compared to the median for all
assays (P 
 0.05). These cosmids have unique restriction pat-
terns and do not carry either the mel1 or mel2 locus. Four of
these cosmids, two that confer enhanced macrophage infection
(mel) and two that confer repressed macrophage infection
(mrl), were chosen for further analysis.
Identification ofM. marinum mel and mrl loci. Physical maps
were constructed for all four cosmids, and the cosmids were in
vitro mutagenized with a chloramphenicol-resistant mini-Mu
transposon. Each cosmid displays a unique NotI physical map
and ranges in size from 44 to 52 kbp (Fig. 6). The exact
locations of transposon insertions in each cosmid were deter-
mined by sequencing out from the transposon. Cosmids that
carried unique transposon insertions in the insert M. marinum
DNA were transformed into M. marinum to evaluate whether
the mutagenized cosmid retained the ability to confer the ex-
pected phenotype for macrophage infection compared to wild-
type M. marinum and the nonmutated cosmid. These assays
were carried out three times independently in triplicate, and
mutagenized cosmids that display a significantly different phe-
notype compared to the original cosmid (P 
 0.05) were con-
cluded to have a transposon insertion in the locus affecting
macrophage infection (Fig. 6). We identified one region from
each cosmid that is involved in either enhancing, designated
mel3 and mel4, or repressing, designated mrl1 and mrl2, mac-
rophage infection by M. marinum. Based on the positions of
each transposon insertion and their effect on the phenotype
conferred by the cosmid, we estimated the approximate size of
FIG. 4. Summary of all data from normalized cell association with the RAW 264.7 murine macrophage cell line for 384 individual clones of M.
marinum carrying an arrayed M. marinum total genomic DNA cosmid library assayed in two independent assays in triplicate. Each data point
represents the normalized mean of triplicate samples. All cell association data are normalized to the median of all library clones arbitrarily set to
1. Horizontal dashed lines indicate one standard deviation from the median, and the horizontal dotted lines indicate two standard deviations from
the median.
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each locus. The mel2 and mel3 loci are somewhat smaller (3 to
6 kbp) than the mrl1 and mrl2 loci (8 to 10 kbp).
In silico and expression analysis of mel and mrl loci. Se-
quences obtained from each transposon insertion were com-
pared to the M. marinum genome available from the M. ma-
rinum Sequencing Group at the Sanger Institute (http://www
.sanger.ac.uk/Projects/M_marinum/). This allowed determination
of the complete sequence of each locus and annotation of the
regions involved (Fig. 7). Quantitative RT-PCR analyses of the
transcript levels of the genes identified within the mel4 and
mrl2 loci confirm that the cosmids 2-G2 and 4-H9 increase
expression of the loci that they carry when present in M. ma-
rinum (Fig. 7), similar to our observations with the cosmid that
carries melF. The loci identified are not clustered in an obvious
fashion in the M. marinum genome and are unique with respect
to previously identified M. marinum virulence determinants.
We analyzed the putative coding regions within these loci for
similarity to other bacterial genes and motifs present within
them to gain insight into their potential functions. Detailed in
silico analysis of the putative ORFs identified in this manner is
described in Table 2. Based on these analyses, the mel3 locus
carries a single ORF that is similar to the mycobacterial PknD,
FIG. 5. Normalized cell association data in the RAW 264.7 murine macrophage cell line for 76 cosmid clones chosen from the original M.
marinum total genomic DNA cosmid library assayed in three independent assays in triplicate. Each data point represents the normalized mean of
triplicate samples. All cell association data are normalized to the mean of all library clones arbitrarily set to 1. Horizontal dashed lines indicate
one standard deviation from the mean. Dashed circles indicate the eight library clones that are significantly different from the mean (P 
 0.05),
and the “**” symbols indicate the four clones chosen for further analyses.
FIG. 6. Physical maps (NotI) of four cosmids, 1-B12, 2-G2, 4-B2, and 4-H9, that affect cell association of M. marinum, approximate total
plasmid and locus size (in parentheses), the positions of transposon insertions, and the phenotype of insertion. Plus markers indicate that the
cosmid carrying a transposon insertion at that location enhances host cell infection, and minus markers indicate that insertion represses host cell
infection. Loci identified by transposon mutagenesis were designated mel for “mycobacterial enhanced infection locus” or mrl for “mycobacterial
repressed infection locus” based upon the phenotype that the original cosmid confers to wild-type M. marinum. All cosmids carrying transposon
insertions were assayed for cell association with the RAW 264.7 murine macrophage cell line three times independently in triplicate to determine
the phenotypic effects that they confer compared to the original cosmid.
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a “eukaryotic-like” serine/threonine kinase that appears to af-
fect regulation through SigF (42, 44, 80). The mel4 locus en-
codes four putative ORFs, two of which are similar to zinc-
dependent proteases and two with unknown functions.
Interestingly, both of the mrl loci identified contain ORFs with
potential involvement in synthesis of the mycobacterial cell
wall. There are five putative ORFs within mrl1 that display
similarity to cell wall biosynthetic proteins in other bacteria
and ten putative ORFs within mrl2 that primarily display sim-
ilarity to lipid biosynthetic proteins. Since lipids are an impor-
tant component of the mycobacterial cell wall, it is possible
that mrl1 and mrl2 are involved in synthesis of modified my-
cobacterial cell wall components, resulting in a composition
that is less conducive to efficient phagocytosis by macrophages
under certain growth conditions.
Mutations in M. marinum mel loci affect infection of mac-
rophages. To eliminate the possibility that the phenotypes con-
ferred by mel and mrl loci are due to artifacts resulting from
overexpression, rather than the natural gene functions, we
constructed mutations in them by allelic exchange and exam-
ined their effects on macrophage infection. Each locus was first
cloned into a suicide plasmid for mycobacteria, pYUB174, and
mutated by in vitro transposon mutagenesis. The exact location
of each transposon insertion was determined by sequencing
FIG. 7. (A) Position of each mel and mrl locus on the M. marinum chromosome as obtained from the M. marinum Sequencing Group at the
Sanger Institute (http://www.sanger.ac.uk/Projects/M_marinum/), size of each locus, deduced gene map of each locus, and structure of regions used
in complementation plasmids. Triangles indicate positions of insertion mutations used to construct M. marinum mutants in each locus by allelic
exchange. (B and C) Quantitative RT-PCR analyses for levels of RNA transcript in wild-type M. marinum and M. marinum carrying cosmids (2-G2
for mel4 and 4-H9 for mrl2) for melM-P genes in the mel4 locus (B) and the mrlI gene in the mrl2 locus (C). The melF gene was used as a control
that should not display changes in expression in the presence of these cosmids. All transcript levels were calculated by the comparative CT method
using 16S rRNA as a comparator. The data shown are the means and standard deviations for two independent experiments carried out in triplicate.
**, significantly different fold increase in expression compared to the melF gene under the same conditions (P 
 0.05).
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from the transposon. We identified insertions in melL, melM,
melN, melO, mrlA, mrlF, mrlG, mrlH, mrlI, mrlK, mrlL, mrlN,
and mrlO using this technique (Fig. 7). Each of these mutations
was then transferred to M. marinum by allelic exchange using
the -galactosidase gene carried by this pYUB174 to screen for
single and double recombination events in a two-step allelic
exchange. Each of the resulting mutants was compared for its
ability to infect macrophages with wild-type M. marinum and
M. marinum carrying the original cosmid (Fig. 8). As expected,
the melL mutant displays a significant defect (P 
 0.01) in
macrophage infection compared to wild-type M. marinum. Al-
though transposon insertions in these genes within the original
mel4 cosmid affect the ability of the cosmid to enhance mac-
rophage infection, melM, melN, and melO mutants do not
display a significant defect in macrophage infection and may
actually display enhanced macrophage infection. We hypothe-
sized that the functional ORF within the mel4 locus might be
melP, rather than the other three genes. Since we did not
obtain a mutation in this gene, we could not test the role of
melP directly, but we examined whether its transcription was
TABLE 2. Characteristics of genes in mel and mrl loci
Gene locus Similar organism (gene)a E value(score)b
% Identity
(no. of aa)c Other similarities or motifs
d Putative activity
mel3
melL M. smegmatis (pknD) 3e-94 (349) 66 (272) S_TKc, DUF477 Serine/threonine kinase
mel4
melM M. tuberculosis (Rv2315c) 0.0 (859) 86 (505) COG0312, Zn-dep.prot. Protease
melN M. tuberculosis (Rv2314c) 0.0 (711) 84 (457) COG0312, Zn-dep.prot. Protease
melO M. tuberculosis (Rv2313) 5e-113 (410) 84 (283) COG2128, unchar.cons.prot. Unknown
melP N. farcinica (nfa42450) 3e-13 (78.6) 52 (91) None Unknown
mrl1
mrlA Arthrobacter sp. (Arth4051) 2e-47 (194) 46 (276) COG1922, teich.ac.syn. Cell wall biogenesis
mrlB M. avium subsp. paratuberculosis
(MAP0964c)
0.0 (704) 71 (507) COG2148, sug.trans.lps,
COG1086, nuc.diph.ep.
Cell wall biogenesis
mrlC M. avium subsp. paratuberculosis
(MAP0963c)
3e-150 (535) 68 (488) pfam01943, polys.syn.,
COG0728, MviN
Cell wall biogenesis
mrlD M. avium subsp. paratuberculosis
(MAP0962c)
0.0 (685) 63 (663) COG1216, glyc.tran.,
pfam00534, glyc.tran1
Cell wall biogenesis
mrlE M. avium subsp. paratuberculosis
(MAP0961c)
8e-125 (449) 72 (349) COG0438, glyc.tran. Cell wall biogenesis
mrl2
mrlF M. avium subsp. paratuberculosis
(MAP3191)
0.0 (646) 87 (370) pfam04209, hom.diox. Phe and Tyr metabolism
mrlG M. avium subsp. paratuberculosis
(MAP3192)
0.0 (711) 87 (392) COG1506, dip.amin.pep. Amino acid transport/metabolism
mrlH M. avium subsp. paratuberculosis
(MAP3193)
0.0 (685) 90 (396) COG1804, acCoA-trans. Lipid transport/metabolism
mrlI M. avium subsp. paratuberculosis
(MAP3194)
2e-104 (381) 81 (301) pfam00682, aldolase Metabolism
mrlJ M. avium subsp. paratuberculosis
(MAP3195)
1e-87 (325) 80 (213) pfam00440, TetR_N,
COG1309, AcrR
Transcriptional regulation
mrlK M. avium subsp. paratuberculosis
(FadE12–3)
0.0 (734) 87 (412) cd00567, ACAD Lipid metabolism
mrlL M. avium subsp. paratuberculosis
(MAP3197)
3e-89 (322) 75 (264) COG1960, ACAD
pfam01636, phosphotr.
Metabolism
mrlM M. avium subsp. paratuberculosis
(MAP3198)
5e-37 (156) 62 (129) COG3631, ketost.isom. Metabolism
mrlN M. avium subsp. paratuberculosis
(MAP3199)
2e-56 (221) 64 (173) pfam04264, YceI Unknown
mrlO M. tuberculosis (Rv3143) 7e-55 (216) 88 (130) Cd00156, sig.rec. Signal receiver
a That is, the organism that carries the protein most similar to that encoded by the M. marinum gene identified, along with the name of the corresponding gene in
that organism in parentheses.
b The expectation frequency (E value) is a parameter that describes the significance of the sequence match and the score of the sequence match according to NCBI
protein-protein BLAST when it is compared to the closest homologue.
c The percent identity at the amino acid (aa) level and the number of amino acids (in parentheses) that could be aligned to show this level of identity.
d This column indicates the placement of the putative protein product into a cluster of orthologues (COG or KOG eukaryotic) using the CD-Search at NCBI and
SignalP v.1.1 at the Center for Biological Sequence Analysis website. COG, clusters of orthologous groups; KOG, clusters of orthologous groups for eukaryotic
genomes; pfam, protein family; cd, conserved domain; S_TKc, serine/threonine protein kinase catalytic domain; DUF477, domain of unknown function found in
Eukarya and Eubacteria; Zn-dep.prot., Zn-dependent proteases; unchar.cons.prot., uncharacterized conserved protein; teich.ac.syn., teichoic acid synthesis proteins;
sug.trans.lps, sugar transferases involved in lipopolysaccharide synthesis; nuc.diph.ep., predicted nucleoside-diphosphate sugar epimerase; polys.syn., polysaccharide
biosynthesis protein; MviN, uncharacterized membrane protein thought to be involved in virulence; glyc.tran., predicted glycosyltransferases; glyc.tran1, glycosyl
transferases group 1; hom.diox., homogentisate 1,2-dioxygenase involved in the metabolism of Phe and Tyr; dip.amin.pep., dipeptidyl aminopeptidases/acylaminoacyl-
peptidases; TetR_N, TetR family bacterial regulatory proteins; AcrR, AcrR family of transcriptional regulators; ACAD, acyl-coenzyme A dehydrogenase; phosphotr.,
phosphotransferase enzyme family; ketost.isom., ketosteroid isomerase; YceI, E. coli YceI-like family of inducible periplasmic proteins; sig.rec., signal receiver domain.
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affected by the insertions in the other ORFs within mel4 (Fig.
9). We found that insertions in each of the mel4 ORFs affected
all genes downstream, with the exception of melP, suggesting
that the melP gene is within a different transcriptional unit
from the other genes within mel4. The phenotype of mutants
that affect macrophage infection was confirmed by microscopy
using acid-fast stains (Table 3). Acid-fast stains revealed sim-
ilar differences in the ability of these mutants and the original
cosmids to infect macrophages, as observed in cell association
assays. Since both viability-based assays, such as cell associa-
tion assays, and microscopy, which is not affected by bacterial
viability, display similar results, it is unlikely that survival in
host cells is solely responsible for their phenotype. Rather, the
observed phenotype is most likely due to differences in mac-
rophage infection.
Mutations within mrl loci enhance macrophage infection.
Since the presence of the mrl loci on cosmids represses infec-
tion of macrophages, most likely due to gene dosage effects, we
expected that mutants in these genes could enhance macro-
phage infection. We found that M. marinum mrlA, mrlG, mrlH,
mrlI, mrlL, and mrlN mutants display enhanced macrophage
infection compared to the wild type (P 
 0.01), whereas mrlF,
mrlK, and mrlO mutants infect macrophages at levels similar to
the wild type (Fig. 8). These observations suggest that mrlF and
mrlO are not required for inhibition of macrophage infection.
This may be the case for mrlK as well, although this mutation
might not interfere with the activity of the protein product due
to its carboxy-terminal position of insertion. However, the
other predicted mrl genes—mrlA, mrlG, mrlH, mrlI, mrlL, and
mrlN—play a role in reducing macrophage infection by wild-
type M. marinum.
Complementation restores wild-type macrophage infection
to mel and mrl mutants. In order to ensure that secondary
mutations had not occurred elsewhere in the M. marinum
chromosome during mutagenesis of the mel and mrl loci, we
transformed each mutant with a plasmid carrying the appro-
priate wild-type chromosomal regions. The mutant, wild-type
and complementing strains were then compared for their abil-
ity to infect macrophages, and we found that complementation
restores the expected phenotype (Fig. 10). The mrlA mutation
could be complemented with the mrlA through mrlC region
alone, so we suspect that either mrlD and mrlE are in a differ-
ent transcriptional unit or they are not required for reduction
of macrophage infection. The mrlI mutation could be comple-
mented by the entire mrl2 locus but not the mrlJ through mrlO
region alone, confirming the importance of mrlI for reduction
of macrophage infection. These data suggest that the genes
within the mel and mrl loci are responsible for the effects of
each cosmid on macrophage infection by M. marinum and that
gene dosage effects allowed identification of novel genes that
are involved in interactions with macrophages by wild-type M.
marinum.
DISCUSSION
Macrophage infection by bacteria involves a complex inter-
play between adherence, phagocytosis, and initial intracellular
survival. Since mycobacteria are thought to replicate primarily
within macrophages during disease, it is likely that proper
interactions with macrophages are critical to pathogenesis. In-
FIG. 8. Cell association of M. marinum wild type, M. marinum
mutants, and M. marinum containing cosmid 1-B12 that carries melL,
2-G2 that carries melMNOP, 4-B2 that carries mrlABCDE, and 4-H9
that carries mrlFGHIJKLMNO with RAW 264.7 cells. The data are
expressed relative to the cell association of wild-type M. marinum that
was included as an internal control in all experiments. The data and
error bars represent the means and standard deviations, respectively,
of three independent experiments carried out in triplicate. **, P
 0.05
compared to wild-type M. marinum.
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fection of macrophages by M. marinum is dependent upon the
stage of growth in laboratory medium, suggesting that the
genes involved in macrophage infection are regulated. This
observation, combined with the ability of gene dosage to in-
crease the expression of genes, was utilized in the present study
to identify M. marinum genes involved in macrophage infec-
tion. This approach is advantageous because it allows the en-
tire genome to be screened using relatively few clones, since
cosmids can contain a large numbers of genes. The conclusion
that this approach allowed identification of genes involved in
the normal interactions of wild-type M. marinum with macro-
phages is supported by the fact that specific mutants in these
genes display the expected phenotype and complementation
results in recovery of the wild-type phenotype. In addition, the
phenotype of each cosmid and mutant was confirmed by mi-
croscopy, which suggests that the effect is on macrophage in-
fection rather than on survival either within the cells or during
the experimental procedure. Furthermore, studies in Salmo-
FIG. 9. RT-PCR studies to evaluate the effects of insertion mutations on expression of melM, melN, melO, and melP in M. marinum.
Approximately equivalent amounts of RNA from M. marinum wild-type and M. marinum melM, melN, melO, and melP mutants were reverse
transcribed and subjected to RT-PCR with specific oligonucleotides within melM, melN, melO, and melP and 16S rRNA. Equal amounts of each
PCR product were loaded on 0.8% agarose gels and compared to the 16S rRNA control RT-PCR for each strain (16S rRNA) carried out on the
same samples in the same manner by ethidium bromide staining (A) and densitometry (B). The data shown are representative of two independent
experiments where similar results were obtained in both.
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nella (54) and Legionella (17, 85) strains have yielded similarly
promising results using comparable strategies to increase ex-
pression of virulence genes to allow their identification by
functional assays.
Gene dosage has been used previously to control regulation
of genes of interest (2, 8, 77) and has been used successfully by
our own group for whole-genome screens for virulence genes
in Legionella (17). One caveat of this approach could be that
operator regions present on the cosmids might saturate regu-
lators, resulting in down- or upregulation of unlinked loci in
the same regulon (50, 53, 77). We have not previously found
unlinked loci that were responsible for the observed pheno-
type, nor was this type of problem observed in the present
study, since mutations in the loci identified display the ex-
pected phenotype. This problem may have been avoided be-
cause our studies have utilized relatively low-copy-number vec-
tors. The mycobacterial origin of replication on our cosmid is
derived from pAL5000, thought to be a low-copy-number plas-
mid (94). This fact most likely allowed relatively subtle en-
hancement of the expression of genes that this plasmid carries
in our library, rather than extremely robust expression that
might be detrimental to bacterial growth in vitro and lead to
pleiotropic effects. The conclusion that this library only results
in subtle increases in expression is supported by our observa-
tion that the presence of a cosmid containing mel2 in M. ma-
rinum increases the expression of melF approximately 5- to
10-fold. This level of expression allowed identification of loci
that are involved in macrophage infection in wild-type M. ma-
rinum, rather than only affecting macrophage infection when
overexpressed. These observations suggest that we are exam-
ining the natural function of these genes, rather than an indi-
rect effect of overexpressing them.
Our initial screen identified 76 cosmids that had the ability
to confer enhanced or repressed macrophage infection to M.
marinum. Some of these were false positives, either because
the cosmid did not confer the expected phenotype after trans-
formation back into M. marinum or because they did not con-
sistently display the same phenotype. A possible reason that
some of the original cosmids did not confer the expected phe-
notype when transformed back into M. marinum is that a
secondary mutation occurred in the bacterial chromosome,
which cannot be transferred. However, it is equally possible
that mutations or rearrangements occur in the cosmids them-
selves as they are passaged back through E. coli. This possibil-
ity could be examined by going back to the original cosmid
clones in E. coli and comparing them to those from M. mari-
num. Cosmids that did not display a consistent phenotype may
do so because they are impacted greatly by the phase of growth
of the culture or their phenotype in macrophages is less obvi-
ous under laboratory conditions. Neither issue makes the
genes that they carry of less interest, although it is equally
possible that they are true negatives. The only clones that we
carried through our entire analysis in the present study were
those that display the expected phenotype in all assays, making
it possible that not all genes that could affect macrophage
infection have been identified, as yet. Further studies to eval-
uate such clones in additional assays are ongoing and may
result in the identification of additional mel and mrl loci.
Most of the M. marinum mel and mrl mutants constructed
had the expected phenotype, but some mutants did not display
a difference in macrophage infection compared to the wild
type. Mutations in the melM, melN, and melO genes do not
affect macrophage infection, although mutations in this locus
on the cosmid affect the enhancement of macrophage infec-
tion. Although this observation could be the result of genetic
buffering or redundancy (46), the absence of an effect of these
mutations on melP expression could also explain these obser-
vations. It appears that melP is expressed from a different RNA
transcript, despite the close proximity to melO. These obser-
vations might suggest that melP is important for the enhanced
macrophage infection phenotype conferred by cosmid 2-G2.
However, it is possible that the melM-O genes are also in-
volved, explaining their apparent impact on macrophage infec-
tion when present on the cosmid, although it is clear that they
are not individually necessary for the function of melP in mac-
rophage infection. If the prediction of protease activity for
MelM and MelN is correct, other proteases might compensate
for a mutation in a single protease, providing functional re-
dundancy. In fact, MelN may compensate for MelM and vice
versa. Construction of a double mutant or deletion of both
genes would provide some of the reagents necessary to test this
possibility. More detailed analysis of this region is needed to
TABLE 3. Infection of murine macrophages
Strain
Mean  SD
% Infected cellsa No. of vacuoles/cellb No. of bacteria/vacuolec Infectivity indexd
M. marinum 14  1.0 1.2  0.6 10  7.8 1.0  0.10
M. marinum::1-B12 51  4.7 2.1  1.3 15  9.8 9.6  0.77*
M. marinum (melL) 3.7  0.9 1.1  0.2 9.5  6.8 0.2  0.05*
M. marinum::2-G2 49  5.2 2.1  1.6 12  8.3 7.4  0.79*
M. marinum::4-B2 6.1  2.3 1.0  0.4 16  13 0.6  0.23†
M. marinum (mrlA) 30  5.3 2.2  1.3 11  6.0 4.3  0.76*
M. marinum::4-H9 7.2  1.1 1.1  0.3 13  9.1 0.6  0.09*
M. marinum (mrlG) 37  2.1 1.9  1.4 11  8.3 4.6  0.06*
M. marinum (mrlL) 28  2.5 1.1  0.6 14  12 2.6  0.23*
a That is, the percentage of cells containing at least one bacterium in a field. The results are the means  standard deviations for three counts of 25 fields.
b That is, the number of bacterial vacuoles in each cell. Results are the means for three counts of 50 cells.
c That is, the number of bacteria in each vacuole. Results are means  the standard deviations for three counts of 50 cells.
d The infectivity index was calculated as follows: (% infected cells  the number of vacuoles per cell  the number of bacteria per vacuole for the strain)/(% infected
cells  the number of vacuoles per cell  the number of bacteria per vacuole for M. marinum). *, Significantly different from wild type M. marinum (P 
 0.01); †,
significantly different from wild-type M. marinum (P 
 0.05).
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better understand the interactions of MelM-O with MelP, par-
ticularly because our bioinformatic analyses provided little in-
formation regarding the predicted functions of these genes.
Mutations in three of the genes—mrlF, mrlK, and mrlL—
within mrl2 did not affect macrophage infection. These obser-
vations may be for reasons similar to those for the melM-O
genes. However, since two of these genes are on the periphery
of the locus, these analyses may have simply allowed a more
refined definition of the functional locus. The need for the
entire region, rather than just the mrlJ-O region, to comple-
ment a mrlI mutation suggest that at least mrlI is required for
repression of macrophage infection. In the case of mrlK, the
mutant may not display a phenotype due to the production of
a functional protein product, since the mutation is very near
the predicted carboxy terminus. Thus, we cannot, at this point,
rule out a role for mrlK in macrophage infection, and the entire
region from mrlG to mrlN may be involved. Construction of
additional mutations and complementing constructs, as well as
more detailed analysis of the biochemical activities of the prod-
uct of each gene, should improve our understanding of the role
of this locus in macrophage infection.
Interestingly, we identified cosmid clones, now designated
mrl for “mycobacterial repressed macrophage infection loci,”
that consistently confer repressed macrophage infection to M.
marinum. This observation may be due to increased expression
of repressors that control macrophage infection or genes that
are involved in antiphagocytic activities. Antiphagocytic activ-
ity is often attributed to capsule on pathogenic organisms (4,
10, 25, 31, 39, 48, 58, 60, 90, 91, 105), which fits well with the
predicted role of the mrl genes in cell wall and lipid biosyn-
thetic pathways. Since tuberculosis and other mycobacteria can
produce capsule (34, 55, 75, 76, 87, 93), it is tempting to
speculate that these genes are involved in the synthesis of a
capsule-like structure during certain stages of infection. How-
ever, it is equally likely that modification to the mycobacterial
cell wall can modulate phagocytosis similar to the cell wall of
M. leprae (70–72). Since mycobacteria are normally considered
intracellular pathogens, the fact that there are stages of myco-
bacterial infection where the bacteria are primarily found ex-
tracellular (26, 56, 61, 99, 100) and may be expressing anti-
phagocytic activities is only rarely examined. Examples of
stages where extracellular bacteria are found during tubercu-
losis include within liquefied lesions, on the periphery of hy-
poxic lesions, and possibly during dissemination (21, 22, 26, 56,
59, 61, 62). Environmental mycobacteria are likely to require
the ability to persist extracellularly for an extended period of
time, particularly in water environments where nutrients are
usually dilute and protozoa that allow intracellular growth (15,
45, 51, 52) may be sparse (40, 43, 63, 102–104). Therefore, it
seems likely that the ability to express an antiphagocytic activ-
ity at specific stages of disease would provide an advantage for
pathogenic and environmental mycobacteria. These observa-
tions emphasize the importance of further studies to better
understand the importance of the genes we have identified
during pathogenesis.
These observations, along with our earlier studies designed
to elucidate the mechanisms used by M. marinum to control
infection of macrophages (32, 66), suggest that interactions of
M. marinum with macrophages are complex and multifaceted.
Although it seems likely that we do not yet have a comprehen-
FIG. 10. Cell association of M. marinum wild type, M. marinum
mutants, and mutants carrying complementing constructs with
RAW 264.7 cells. All data are expressed relative to the cell associ-
ation of wild-type M. marinum that was included as an internal
control in all experiments. The data and error bars represent the
means and standard deviations, respectively, of three independent
experiments carried out in triplicate. **, P 
 0.01 compared to
wild-type M. marinum.
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sive picture of how M. marinum parasitizes macrophages, we
did recover the mel1 and mel2 loci previously identified (32),
confirming that these loci are important for interactions with
macrophages and that our screen was relatively comprehen-
sive. Four additional cosmids, beyond those characterized here
in detail, were identified that display unique restriction maps
and do not carry previously recognized macrophage infection
loci. Studies are ongoing to better characterize these cosmids,
which should provide additional insight into the molecular
mechanisms of macrophage infection and may identify overlap
with our earlier screen by transposon mutagenesis (66). Con-
tinued analysis of the molecular mechanisms of action of these
macrophage infection loci should provide us with a much bet-
ter understanding of this complex, but critical, aspect of my-
cobacterial pathogenesis.
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